Omicron evolution drives increased ciliated cell tropism and dysfunction in nasal epithelia.

1. Problem Statement

While it is established that SARS-CoV-2 Omicron variants exhibit superior replication efficiency in the upper respiratory tract compared to the ancestral strain and the Delta variant, the specific mechanisms driving this shift remain incompletely understood. Previous hypotheses suggest stronger interactions with motile cilia in human nasal epithelial cells (NECs) may be a factor. However, there has been a lack of comprehensive investigation comparing how different Omicron sub-lineages (specifically BA.1, BA.5, and XBB) interact with ciliated cells and affect their function. The study aims to elucidate the evolutionary trajectory of these variants regarding ciliated cell tropism and the resulting impact on ciliary function and host response.

2. Methodology

The researchers employed a multi-faceted experimental approach using differentiated primary human nasal epithelial cell (NEC) cultures, which closely mimic the in vivo airway environment.

• Viral Strains: The study compared an ancestral isolate (QLD02) against three Omicron variants: BA.1, BA.5, and XBB.
• Transcriptomic Analysis: RNA sequencing was performed to analyze host gene expression changes at 48 hours post-infection (hpi).
• Immunofluorescence (IF): Used to visualize and quantify nucleocapsid-positive cells and assess the specific tropism for ciliated cells.
• Protein Analysis: Western blotting or immunofluorescence targeting specific ciliary proteins (e.g., DNAH5) to assess structural integrity and motility machinery.
• Apoptosis Assays: Evaluation of cell death in both infected and bystander cells.

3. Key Contributions

• Comparative Evolutionary Analysis: This is the first comprehensive study directly comparing the interactions of multiple Omicron sub-variants (BA.1, BA.5, XBB) with ciliated NECs against an ancestral strain.
• Decoupling Tropism from Structural Loss: The study distinguishes between increased viral entry (tropism) and the actual physical loss of ciliated cells, revealing that dysfunction can occur without overt cell death or loss of cilia numbers.
• Identification of a "BA.5/XBB Signature": The research identifies a specific molecular phenotype emerging in later Omicron variants that was absent in BA.1 and the ancestral strain, characterized by profound ciliary dysfunction.

4. Key Results

• Enhanced Ciliated Cell Tropism:
  • Both BA.1 and BA.5 showed significantly higher tropism for ciliated cells compared to the ancestral QLD02 strain (7.6-fold and 9-fold increases, respectively).
  • Immunofluorescence revealed a 13-fold increase in nucleocapsid-positive cells for BA.5 relative to QLD02.
• Transcriptional Reprogramming (The BA.5/XBB Signature):
  • Unlike BA.1 and QLD02, infection with BA.5 and XBB triggered a distinct host response at 48 hpi.
  • This response was defined by the profound downregulation of genes essential for cilium assembly and function.
  • Concurrently, there was a strong upregulation of pro-apoptotic and inflammatory pathways.
• Ciliary Dysfunction vs. Cell Loss:
  • Despite elevated apoptosis in infected and bystander cells, the total number of ciliated cells remained unchanged post-infection.
  • However, BA.5 infection caused a significant reduction in DNAH5 (an outer dynein arm protein), a critical component for ciliary motility. This indicates that the virus causes functional paralysis of the cilia rather than their physical destruction.
• Evolutionary Stepwise Progression:
  • Ancestral/BA.1: Exhibit increased tropism but do not induce the specific ciliary dysfunction signature.
  • BA.5/XBB: Retain the high tropism and apoptosis features of earlier variants but add a layer of severe ciliary dysfunction (transcriptional and protein-level) that compromises mucociliary clearance.

5. Significance

The study provides critical insights into the pathogenesis of SARS-CoV-2 evolution at the nasal barrier. It demonstrates that while increased ciliated cell tropism is a conserved feature of Omicron variants, the progressive evolution toward BA.5 and XBB has introduced a mechanism for ciliary dysfunction.

This dysfunction, mediated by the downregulation of assembly genes and the degradation of motility proteins (like DNAH5), likely impairs the mucociliary escalator—the primary defense mechanism of the upper airway. This impairment could explain the increased viral load and transmission efficiency of later Omicron variants, as the host's ability to clear the virus from the nasal cavity is compromised even before the ciliated cells are physically lost. These findings highlight ciliary dysfunction as a potential therapeutic target to mitigate transmission and severity in future SARS-CoV-2 variants.